Imaging the HIV Reservoir

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 18, 2018

Primary Completion Date

February 1, 2020

Study Completion Date

April 1, 2020

Conditions
HIV
Interventions
DRUG

3BNC117-Copper-64

3 mg/kg 3BNC117 combined with radio-isotope Copper-64

Trial Locations (1)

3004

Alfred Health, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

The Peter Doherty Institute for Infection and Immunity

OTHER

collaborator

Monash University

OTHER

collaborator

Monash Health

OTHER

collaborator

Rockefeller University

OTHER

collaborator

Austin Health

OTHER_GOV

lead

Bayside Health

OTHER_GOV